Spinal bulbar muscular atrophy (SBMA) causes a loss of motor neurons in the spinal cord and brainstem. It mainly affects facial and swallowing muscles and the muscles in the arms and legs. Previously, ...
Tetramethylpyrazine nitrone was safe for ALS patients in a phase II trial. The investigational agent did not outperform placebo on the primary efficacy outcome. However, the treatment showed possible ...
The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results